Market Overview

Benzinga's Top Downgrades

Share:
Related BMRN
Your Guide To 2017's Emerging Pharmaceuticals Catalysts
Benzinga's Top Upgrades, Downgrades For February 7, 2017
Biotech Forum Daily Digest: Can Aerie Pharmaceuticals Continue To Rally? Spotlight On OncoMed Pharmaceuticals (Seeking Alpha)
Related PEG
10 Stocks To Watch For February 24, 2017
Earnings Scheduled For February 24, 2017
Public Service Enterprise Group (PEG) Q4 2016 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at Deutsche Bank downgraded BioMarin Pharmaceutical (NASDAQ: BMRN) from “buy” to “hold.” BioMarin's shares closed at $38.70 on Friday. BioMarin's trailing-twelve-month ROE is -11.59%.

Analysts at FBR Capital downgraded Public Service Enterprise Group (NYSE: PEG) from “market perform” to “underperform.” PSEG's stock closed at $32.13 on Friday. PSEG's PEG ratio is 6.66.

Analysts at KeyBanc Capital downgraded Ignite Restaurant Group (NASDAQ: IRG) from “buy” to “hold.” Ignite Restaurant's shares closed at $15.12 on Friday. Ignite Restaurant's trailing-twelve-month profit margin is 2.99%.

UBS downgraded Westlake Chemical (NYSE: WLK) from “neutral” to “sell.” Westlake Chemical's shares closed at $69.50 on Friday. Westlake Chemical's trailing-twelve-month ROA is 9.24%.

Latest Ratings for BMRN

DateFirmActionFromTo
Feb 2017Morgan StanleyInitiates Coverage OnOverweight
Jan 2017Credit SuisseAssumesOutperformOutperform
Nov 2016BarclaysDowngradesOverweightEqual-Weight

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BMRN + IRG)

View Comments and Join the Discussion!